Skip to main content

Table 1 Subject demographics for the study population (all enrolled subjects)

From: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

Characteristic

Regimen A (n = 12)

Regimen B (n = 15)

Male, n (%)

12 (100)

15 (100)

Caucasian, n (%)

12 (100)

15 (100)

Age, years (median [range])

33 (25-44)

33 (21-44)

Body height, cm (median [range])

184 (169-192)

180 (168-185)

Body weight, kg (median [range])

83 (66-95)

75 (61-97)

Body mass index, kg/m2 (median [range])

25 (23-28)

24 (21-30)

Smoking status, n

  

   Ex-smoker

2

4

   Current

3

6

   Never

7

5